Better Therapeutics, Inc.
BTTXDelisted- Industry
- Services-Health Services
- SEC CIK
- 0001832415
Better Therapeutics, Inc. was delisted in 2026; its insiders filed their last Form 4 on Feb 13, 2024; 1 institution reported holding it in 13F filings for Q4 2025, worth $0 in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Better Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Better Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Perry David P | Executive Chairman | 2,416,634 | Feb 13, 2024 | 0 |
| David P. Perry 2015 Trust | 10% Owner | 2,416,634 | Feb 13, 2024 | 0 |
| Lavizzo-Mourey Risa J | Director | 13,750 | Dec 20, 2023 | 0 |
| Karbe Frank | Chief Executive Officer | 526,516 | Dec 20, 2023 | 0 |
| Carmona Richard H | Director | 157,369 | Dec 20, 2023 | 0 |
| Parker Geoffrey M. | Director | 1,031,805 | Dec 20, 2023 | 0 |
| Granger Elder | Director | 39,601 | Dec 20, 2023 | 0 |
| Armanino Andrew J. | Director | 17,084 | Dec 20, 2023 | 0 |
| Wynholds Kristin | Chief Product Officer | 225,631 | Dec 20, 2023 | 0 |
| Berman Mark A. | Chief Medical Officer | 448,140 | Dec 20, 2023 | 0 |
| Miller Leslie A. | Principal Accounting Officer | 17,937 | Dec 20, 2023 | 0 |
| Heinen Mark | Chief Financial Officer | 139,723 | Apr 21, 2023 | 0 |
| Liu Suying | Director | 0Indirect | Jun 10, 2022 | 0 |
| Zamirowski Justin | Chief Commercial Officer | 36,913 | Jun 1, 2022 | 0 |
| Appelbaum Kevin J | Chief Executive Officer | 6,250 | Apr 4, 2022 | 0 |
| Kevin Appelbaum, or his successor(s), as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020, as amended | 10% Owner | 6,250 | Apr 4, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 31, 2023 (view filing) | Jul 27 | 4 days | Perry David PExecutive Chairman | PPurchase | +1.23M | $0.73 | +$900.1K | +10.5%13.0M after | |
| Jul 31, 2023 (view filing) | Jul 27 | 4 days | Berman Mark A.Chief Medical Officer | PPurchase | +54.8K | $0.73 | +$40.0K | +16.4%388.2K after | |
| Jul 31, 2023 (view filing) | Jul 27 | 4 days | Armanino Andrew J.Director | PPurchase | +274.0K | $0.73 | +$200.0K | +60.3%728.4K after | |
| Jul 31, 2023 (view filing) | Jul 27 | 4 days | Granger ElderDirector | PPurchase | +34.3K | $0.73 | +$25.0K | +2,140.7%35.9K after | |
| Jul 31, 2023 (view filing) | Jul 27 | 4 days | Karbe FrankChief Executive Officer | PPurchase | +137.0K | $0.73 | +$100.0K | +46.9%429.4K after | |
| Jul 31, 2023 (view filing) | Jul 27 | 4 days | Parker Geoffrey M.Director | PPurchase | +685.0K | $0.73 | +$500.1K | +199.7%1.03M after | |
| May 18, 2023 (view filing) | May 16 | 2 days | Granger ElderDirector | PPurchase | +600 | $0.87 | +$522 | +60.0%1.60K after | |
| Apr 12, 2023 (view filing)9:44 PM ET | Apr 10 | 2 days | Perry David P and 1 otherSee Remarks | PPurchase | +4.97M | $0.825 | +$4.10M | New position3.64M after | 2 lots |
| Apr 12, 2023 (view filing) | Apr 10 | 2 days | Karbe FrankSee Remarks | PPurchase | +242.4K | $0.83 | +$201.2K | +484.8%292.4K after | |
| Apr 12, 2023 (view filing) | Apr 10 | 2 days | Parker Geoffrey M.Director | PPurchase | +303.0K | $0.83 | +$251.5K | +757.6%343.0K after | |
| Apr 12, 2023 (view filing) | Apr 10 | 2 days | Armanino Andrew J.Director | PPurchase | +303.0K | $0.83 | +$251.5K | +200.2%454.4K after | |
| Sep 19, 2022 (view filing)6:06 AM ET | Sep 15-16 | 4 days | Perry David P and 1 otherSee Remarks | PPurchase | +50.0K | $2.05 | +$102.6K | +97.0%101.5K after | 2 lots |
| Sep 15, 2022 (view filing) | Sep 15 | Same day | Karbe FrankSee Remarks | PPurchase | +50.0K | $2.09 | +$104.5K | New position50.0K after | |
| Sep 14, 2022 (view filing) | Sep 12-13 | 2 days | Heinen MarkSee Remarks | PPurchase | +50.0K | $1.94 | +$97.0K | +250.0%70.0K after | 2 lots |
| Jun 28, 2022 (view filing) | Jun 24 | 4 days | Heinen MarkSee Remarks | PPurchase | +2.28K | $1.75 | +$3.99K | New position2.28K after | |
| Jun 16, 2022 (view filing) | Jun 14 | 2 days | Armanino Andrew J.Director | PPurchase | +15.0K | $1.39 | +$20.9K | New position15.0K after | |
| Jun 14, 2022 (view filing) | Jun 13 | 1 day | Parker Geoffrey M.Director | PPurchase | +25.0K | $1.45 | +$36.3K | +166.7%40.0K after | |
| Jun 10, 2022 (view filing) | Jun 10 | Same day | Heinen MarkSee Remarks | PPurchase | +5.00K | $1.56 | +$7.80K | +33.3%20.0K after | |
| Jun 10, 2022 (view filing) | Jun 9 | 1 day | Armanino Andrew J.Director | PPurchase | +25.0K | $1.65 | +$41.3K | +19.8%151.3K after | |
| Apr 4, 2022 (view filing)4:27 PM ET | Mar 31 | 4 days | Appelbaum Kevin J and 1 otherChief Executive Officer | PPurchase | +2.50K | $1.97 | +$4.92K | +66.7%6.25K after | |
| Apr 4, 2022 (view filing) | Mar 31 | 4 days | Heinen MarkSee Remarks | PPurchase | +5.00K | $1.98 | +$9.90K | +50.0%15.0K after | |
| Mar 31, 2022 (view filing) | Mar 29 | 2 days | Armanino Andrew J.Director | PPurchase | +40.0K | $2.14 | +$85.6K | +46.3%126.3K after | |
| Mar 31, 2022 (view filing) | Mar 29 | 2 days | Parker Geoffrey M.Director | PPurchase | +15.0K | $2.15 | +$32.3K | New position15.0K after | |
| Dec 23, 2021 (view filing) | Dec 21 | 2 days | Lavizzo-Mourey Risa JDirector | PPurchase | +10.0K | $4.60 | +$46.0K | New position10.0K after | |
| Dec 22, 2021 (view filing)6:03 PM ET | Dec 20 | 2 days | Appelbaum Kevin J and 1 otherChief Executive Officer | PPurchase | +1.00K | $4.60 | +$4.60K | +36.4%3.75K after | |
| Dec 17, 2021 (view filing)8:43 PM ET | Dec 15 | 2 days | Appelbaum Kevin J and 1 otherChief Executive Officer | PPurchase | +750 | $4.71 | +$3.53K | +37.5%2.75K after | |
| Dec 16, 2021 (view filing) | Dec 14 | 2 days | Parker Geoffrey M.Director | PPurchase | +20.0K | $4.94 | +$98.8K | +60.0%53.3K after | |
| Dec 15, 2021 (view filing) | Dec 13-15 | 2 days | Heinen MarkSee Remarks | PPurchase | +3.33K | $4.92 | +$16.4K | +50.0%10.0K after | 3 lots |
| Dec 15, 2021 (view filing) | Dec 13 | 2 days | Armanino Andrew J.Director | PPurchase | +21.0K | $5.48 | +$115.1K | +32.1%86.3K after | |
| Dec 14, 2021 (view filing)5:32 PM ET | Dec 10 | 4 days | Appelbaum Kevin J and 1 otherChief Executive Officer | PPurchase | +1.00K | $5.98 | +$5.98K | +100.0%2.00K after | |
| Dec 7, 2021 (view filing) | Dec 3 | 4 days | Granger ElderDirector | PPurchase | +1.00K | $6.66 | +$6.66K | New position1.00K after | |
| Dec 6, 2021 (view filing)5:34 PM ET | Dec 2-3 | 4 days | Appelbaum Kevin J and 1 otherChief Executive Officer | PPurchase | +1.00K | $6.63 | +$6.63K | New position1.00K after | 2 lots |
| Dec 1, 2021 (view filing) | Nov 29 | 2 days | Armanino Andrew J.Director | PPurchase | +17.0K | $6.96 | +$118.3K | +35.2%65.3K after | |
| Nov 1, 2021 (view filing)8:55 PM ET | Apr 30-May 26 | 185 daysLate | Perry David P and 1 otherSee Remarks | PPurchase | +51.5K | $9.94 | +$512.4K | New position51.5K after | 7 lots |
| Nov 1, 2021 (view filing)8:55 PM ET | Oct 28 | 4 days | Perry David P and 1 otherSee Remarks | PPurchase | +200.0K | $10.00 | +$2.00M | +1.9%10.7M after |